1. Home
  2. RLAY vs RBA Comparison

RLAY vs RBA Comparison

Compare RLAY & RBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • RBA
  • Stock Information
  • Founded
  • RLAY 2015
  • RBA 1958
  • Country
  • RLAY United States
  • RBA United States
  • Employees
  • RLAY N/A
  • RBA N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • RBA Business Services
  • Sector
  • RLAY Health Care
  • RBA Consumer Discretionary
  • Exchange
  • RLAY Nasdaq
  • RBA Nasdaq
  • Market Cap
  • RLAY 619.0M
  • RBA 21.4B
  • IPO Year
  • RLAY 2020
  • RBA 1998
  • Fundamental
  • Price
  • RLAY $4.70
  • RBA $118.08
  • Analyst Decision
  • RLAY Strong Buy
  • RBA Buy
  • Analyst Count
  • RLAY 13
  • RBA 5
  • Target Price
  • RLAY $18.00
  • RBA $120.40
  • AVG Volume (30 Days)
  • RLAY 1.2M
  • RBA 881.9K
  • Earning Date
  • RLAY 11-05-2025
  • RBA 11-07-2025
  • Dividend Yield
  • RLAY N/A
  • RBA 1.05%
  • EPS Growth
  • RLAY N/A
  • RBA 14.00
  • EPS
  • RLAY N/A
  • RBA 2.03
  • Revenue
  • RLAY $8,355,000.00
  • RBA $4,418,000,000.00
  • Revenue This Year
  • RLAY $31.55
  • RBA $6.23
  • Revenue Next Year
  • RLAY N/A
  • RBA $4.88
  • P/E Ratio
  • RLAY N/A
  • RBA $58.13
  • Revenue Growth
  • RLAY N/A
  • RBA 4.66
  • 52 Week Low
  • RLAY $1.78
  • RBA $78.08
  • 52 Week High
  • RLAY $8.19
  • RBA $118.79
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 74.35
  • RBA 61.97
  • Support Level
  • RLAY $4.05
  • RBA $116.12
  • Resistance Level
  • RLAY $4.34
  • RBA $118.91
  • Average True Range (ATR)
  • RLAY 0.27
  • RBA 1.71
  • MACD
  • RLAY 0.05
  • RBA 0.01
  • Stochastic Oscillator
  • RLAY 99.17
  • RBA 87.54

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About RBA RB Global Inc.

RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.

Share on Social Networks: